Reducing harmful chromium levels in water using natural microorganisms
Intensified, High-Rate Reductive Immobilization of Hexavalent Chromium
This study is working on a new way to clean water by using special natural microorganisms to safely reduce harmful levels of chromium, a substance that can cause cancer, making it easier and cheaper to keep our water safe and healthy.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Microvi Biotech, INC. NIH-funded |
| Lab location | 1 site (Hayward, United States) |
| Project ID | NIH-10707077 on NIH RePORTER |
What this research studies
This research focuses on developing a new biological process to effectively reduce hexavalent chromium (Cr(VI)) levels in water, which is known to be carcinogenic. By utilizing specially selected natural microorganisms, the project aims to convert toxic chromium into less harmful forms that can be easily removed from water. The approach involves creating biocatalysts that house these microorganisms, allowing for enhanced performance in reducing chromium concentrations to very low levels. This innovative technology seeks to address the limitations of current remediation methods, making it more cost-effective and environmentally sustainable.
Who could benefit from this research
Good fit: Ideal candidates for this research include communities and water providers dealing with high levels of hexavalent chromium in their water supply.
Not a fit: Patients living in areas without chromium contamination or those not exposed to contaminated water sources may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve water safety by reducing toxic chromium levels, thereby protecting public health.
How similar studies have performed: Previous research has shown promise in using biological methods for metal remediation, indicating that this approach could be effective.
Where this research is happening
Hayward, United States
- Microvi Biotech, INC. — Hayward, United States (Active)
Researchers
- Principal investigator: Shirazi, Fatemeh — Microvi Biotech, INC.
- Study coordinator: Shirazi, Fatemeh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.